Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

FHS
May 17, 2024
6:23 pm

A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment.

Bluebird in fundraising mode: A $150M public offering and a deal to get cash early from gene therapy sales

Facing a financial void it had hoped to be filled by a priority review voucher, bluebird bio is tapping two different sources to bring in

December 20, 2023

Pharmalittle: We’re watching more positive data for Ozempic, a Lilly factory expansion, and more

It’s an honor to fill in for Ed Silverman this morning. There is only one Pharmalot, but when he’s out, his fellow STAT coffee and

May 24, 2024

Biden’s SOTU highlights pharma’s biggest political problem: It is terrifyingly, awfully alone

If you’re a drug company executive, you probably feel like you got up on the wrong side of bed. On Thursday night, President Biden proposed

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.